Company Profile

Hebei Xingbai Pharmaceutical Group
Year Established : 1987
Total Assets(USD) : choose not to disclose
Total Number of Staff : more than 500
Main Competitive Advantages : Brandname,International Approvals/Standards,Experienced R&D Staff,Delivery Term,Production capacity,Large Product Line,Small Orders Accepted,Quality Service
  • Contact Person :
  • Fax:

Hebei Xingbai Pharmaceutical Group.,Ltd is a leading API manufacturer of abamectin, Enramycin and Chlortetracycline Premix. It is established in 1987, the leading products are abamectin, Ivermectin, Emamectin benzoate, Enramycin premix and Chlortetracycline premix. Xingbai group is the largest manufacturer of abamectin and Enramycin premix, Its product process conforms to GMP, and Xingbai is accredited by Chinese GMP, and ISO9001.

Certificates/Standards
PharmaSources Customer Service